Printer Friendly

MILLER, AVERY DENNISON CHAIRMAN, NAMED TO ICN PHARMACEUTICALS' BOARD

 COSTA MESA, Calif., April 26 /PRNewswire/ -- Charles D. Miller, chairman and chief executive officer, Avery Dennison Corp., the worldwide manufacturer of self-adhesive and office products, has been elected to the board of directors of ICN Pharmaceuticals Inc. (NYSE: ICN).
 Headquartered in Pasadena, Calif., Avery Dennison employs 16,500 in more than 200 manufacturing facilities and sales offices in 24 countries. With 1992 sales of $2.6 billion, Avery Dennison ranks number 177 on the Fortune 500 list of the largest U.S. companies.
 Miller became chairman and chief executive officer of Avery Dennison in 1983 following a 20-year career during which he held increasingly responsible positions, including being named president and chief operating officer in 1975 and president and chief executive officer in 1977. Previously, Miller was an executive with Booz, Allen & Hamilton Inc. and the Yale and Towne Manufacturing Co.
 A graduate of Johns Hopkins University, Miller also is on the board of the Pacific Mutual Life Insurance Co., Southern California Edison, the Great Western Financial Corp. and Nationwide Health Properties Inc. He is a trustee of Johns Hopkins University and Occidental College and is past chairman of the Los Angeles Chamber of Commerce and member of the executive committee of the California Business Roundtable.
 "Mr. Miller's extensive financial and international business background make him a significant addition and we are privileged to have him on our board," said Milan Panic, ICN chairman and chief executive officer.
 ICN Pharmaceuticals Inc., headquartered in Costa Mesa, is a worldwide health care company that manufactures, markets and distributes a wide range of prescription and non-prescription pharmaceuticals, biotechnology research products and medical diagnostics worldwide. It is a leader in the research and development of antivirals.
 -0- 4/26/93
 /CONTACT: Paul Knopick of ICN Pharmaceuticals, 714-545-0100, ext. 2465/
 (ICN)


CO: ICN Pharmaceuticals Inc.; Avery Dennison Corp. ST: California IN: MTC SU: PER

MS-JB -- LA006 -- 0485 04/26/93 09:10 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 26, 1993
Words:318
Previous Article:IVAX ANNOUNCES PROPOSED ACQUISITION OF THE INDUSTRIAL AND INSTITUTIONAL CLEANING PRODUCTS BUSINESS OF ELF ATOCHEM NORTH AMERICA, INC.
Next Article:THREE-FIVE SYSTEMS APPOINTS NEW VICE PRESIDENT OF OPERATIONS
Topics:


Related Articles
ICN AND SUBSIDIARY COMPANIES ANNOUNCE MANAGEMENT APPOINTMENTS
AVERY DENNISON FORMS SUPPLIER PARTNERSHIP WITH JOHNSON & JOHNSON
AVERY DENNISON NAMES McCUE VICE PRESIDENT, CORPORATE VALUE PLANNING AND DEVELOPMENT
AVERY DENNISON NAMES SHAW GROUP VICE PRESIDENT, AUTOMOTIVE AND GRAPHIC SYSTEMS GROUP
AVERY DENNISON NAMES MILLER VICE PRESIDENT AND CONTROLLER
DAVIDS0N & ASSOCIATES INC. ANNOUNCES 2-FOR-1 STOCK SPLIT; APPOINTS TWO NEW MEMBERS TO BOARD OF DIRECTORS
Baxter Announces Board Appointments to its Planned Cardiovascular Spin-Off Company.
David Batchelder Resigns From ICN Board.
Two Corporate Business Leaders Elected to ICN Pharmaceuticals Board of Directors.
ICN Pharmaceuticals Announces Results of Annual Meeting of Stockholders.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters